SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?


To: Israel who wrote (20939)1/20/2000 10:37:00 AM
From: dkgross  Read Replies (1) | Respond to of 150070
 
ECNC having a lovely morning as well :>) Can't beleive I got in at .18.....



To: Israel who wrote (20939)1/20/2000 10:41:00 AM
From: SSP  Read Replies (1) | Respond to of 150070
 
LITH - Lithium Technology Corporation and Pacific Lithium Limited Sign Merger
Agreement

PLYMOUTH MEETING, Pa., Jan. 20 /PRNewswire/ -- Lithium Technology
Corporation ("LTC", "the Company") (OTC Bulletin Board: LITH) and Pacific
Lithium Limited (PLL) of New Zealand announced today that they have signed the
definitive merger agreement following approval by LTC's Board of Directors
(see LTC Press Release of October 6, 1999). The merger is subject to the
approval of the LTC shareholders, which will require the filing of a proxy
statement with the S.E.C., and the approval of the PLL shareholders.
Under the terms of the transaction, LTC and PLL would merge into a new
U.S. corporation - Ilion Technology Corporation - concurrent with an Initial
Public Offering (IPO) and Nasdaq listing of Ilion, planned for later this
year. The offering will be made only by means of a prospectus. At the time
of the IPO, LTC's shareholders would exchange their LTC shares for
3,500,000 shares of Ilion stock on a pro-rata basis.
Since the original announcement in October, the merger transaction has
been restructured as a tax free reorganization. According to the original
terms, the merger would have occurred upon LTC shareholder approval and would
have resulted in the transfer of all LTC assets to PLL in exchange for PLL
stock, with the Ilion IPO occurring at a later date. Under the restructuring,
the transfer of assets and technology will occur simultaneously with the Ilion
IPO.
Beginning in October 1999, and until the IPO, PLL has assumed
responsibility for covering all of LTC's operating cash flow requirements. If
the merger is not consummated for any reason, all cash advances from PLL to
LTC will be converted into common stock and except in the event of a PLL
default, warrants and certain licensing and security arrangements.
Ilion is expected to have a unique position in the lithium polymer battery
markets, providing a proprietary vertical integration capability that will
range from ultra high grade lithium materials to reinforced composite battery
structures, high yield thin film manufacturing processes and lithium
recycling. This blending of technologies, capabilities and people will enable
the new company to become a low cost provider of high quality and high
performance lithium polymer battery cells. Targeted end user applications
include the portable electronics market, particularly notebook computers and
PDAs, as well as the rapidly emerging Hybrid Electric Vehicle (HEV) market.
From now until the IPO the two companies are operating as partners in
pursuing lithium polymer battery opportunities worldwide, with LTC serving as
full time exclusive consultants to PLL. According to Mr. Robin Johannink,
PLL's Managing Director: "The combination of PLL and LTC will serve as the
catalyst for a wide range of new initiatives to secure a preeminent position
in the global lithium polymer battery markets." LTC's Chairman & CEO, Mr.
David J. Cade, said: "Approval by the LTC Board and signing of the formal
merger agreement documents are critical steps in the process to complete the
merger. We are confident that our shareholders will recognize the inherent
value of uniting the two companies into a globally prominent new U.S. public
corporation and will approve the merger."
PLL is an unlisted New Zealand public company with more than
600 shareholders and access to sources of capital in New Zealand, Australia,
Japan, Singapore and the U.S. It has exclusive licensing arrangements with
the Massachusetts Institute of Technology and the National Research Council of
Canada to commercialize proprietary electrode and electrolyte polymers. PLL
is already a significant supplier of high quality battery-specific lithium
carbonate to Japanese cathode and electrolyte suppliers. Furthermore PLL has
developed and is sampling customers with patented high temperature stable,
layered manganese cathode materials which should be ideally suited for both
the HEV and portable applications markets. PLL's plant to commercially
produce these cathode materials will be commissioned in early 2000. PLL's
proprietary technology also includes the capability to reclaim and recycle
lithium from depleted batteries.
Lithium Technology Corporation is in the late stages of developing and
seeking to commercialize a new generation of high performance, solid state
rechargeable lithium ion polymer battery cells for portable electronics
devices and other applications such as HEVs. LTC's pilot line production
operations are regularly producing three generic sizes of thin flat cells,
including a large 9 Ah cell (4"x8"x1/4"). The Company's patented and
proprietary technology uses high performance fibers in composite battery
structures and low cost continuous flow fiber web coating and laminating
processes for manufacturing. These new battery cells represent a significant
benefit to the end-user in terms of longer run times and thinner, flatter,
lighter-weight form factors.

The foregoing information contains forward-looking statements which
involve risks and uncertainties relating to such matters as financial
performance, technology development, capital raising, business prospects,
strategic partnering and similar matters. A variety of factors could cause
LTC's actual results and experience to differ materially from anticipated
results or other expectations expressed in these forward-looking statements.

SOURCE Lithium Technology Corporation
-0- 01/20/2000
/CONTACT: (USA), David J. Cade, Chairman & CEO of Lithium Technology,
610-940-6090, or fax, 610-940-6091, or E-mail, dcade@lithiumtech.com, or
(NZ), Robin T. Johannink, Managing Director of Pacific Lithium Limited,
011-64-9-309-5221, or 011-64-9-307-1749, or E-mail,
robin@pacificlithium.co.nz/
/Web site: lithiumtech.com /
(LITH)



To: Israel who wrote (20939)1/20/2000 11:10:00 AM
From: Israel  Read Replies (2) | Respond to of 150070
 
HICS now .95 X 1 and going higher... almost too easy.. CHeck out todays news..lol

(COMTEX) B: Hydrogiene ''Medigard'' Anti-Bacterial Coatings and Spray
B: Hydrogiene ''Medigard'' Anti-Bacterial Coatings and Spray Development

SAN DIEGO, Jan 20, 2000 (BUSINESS WIRE) -- Charles Kallmann,
president/CEO stated Thursday that Polymer Research (Nasdaq:PROA) has
advised completion of Hydrogiene's (OTCBB:HICS) proprietary, advanced,
new, anti-bacterial protection sprays (powder) and coatings program is
expected to be ready for marketing in late April or early May of this
year.

The FDA approved spray and coatings are designed for application to all
Hydrogiene Mediclenze and Theraclenze products and accessories.
Hydrogiene intends to sell the products as a purse sized spray, as well
as a commercially sized spray for use by hotels, restaurants, medical
facilities, military and residential use. The company will license
"Medigard" on an international basis, as well. Medigard is formulated
to kill a wide variety of bacteria such as various strains of E-Coli,
Staf, salmonella, gonorrhea, syphilis, herpes and 13 other such
bacteria. "Medigard" is resistant to cleaning, autoclaving, heat and
other such cleansing and sterilization processes, with a four-year
killing period. World wide patent protection will be sought.

Polymer Research is unique in its field having developed a method of
attaching formulations to substances in such a manner as to make them
virtually impossible to detach or destroy when applied to materials,
meant to protect sealing and killing contaminants.

Market reaction to the new "Medigard" anti-bacterial coating has been
widespread in its enthusiasm for such a protective coating intended to
drastically reduce infections from surfaces potentially harmful to
individuals.

Safe Harbor for Forward-Looking Statements: Except for historical
information contained herein, the statements in this news release are
forward looking statements that are made pursuant to the Safe Harbor
provisions of the Private Securities Reform Act of 1995.
Forward-looking statements involve known and unknown risks and
uncertainties, which may cause the company's actual results in future
periods to differ from forecasted results.



Copyright (C) 2000 Business Wire. All rights reserved.



Distributed via COMTEX.
-0-
CONTACT: Hydrogiene Corp., San Diego
Charles Kallmann, 877/994-9376

WEB PAGE: businesswire.com

GEOGRAPHY: CALIFORNIA

INDUSTRY CODE: MEDICAL

Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.

*** end of story ***